2022-07-12
What are the effects of reshoring the generic active pharmaceutical ingredient (API) manufacturing on the medicine availability in Europe?
Publication
Publication
Additional Metadata | |
---|---|
, , | |
Lemmens, Stef, de Vries, Harwin | |
hdl.handle.net/2105/63645 | |
Supply Chain Management | |
Organisation | Rotterdam School of Management |
Nguyen, Ngoc. (2022, July 12). What are the effects of reshoring the generic active pharmaceutical ingredient (API) manufacturing on the medicine availability in Europe?. Supply Chain Management. Retrieved from http://hdl.handle.net/2105/63645
|